Conduit Pharmaceuticals CDT 深 滬
等待開盤 08-22 09:30:00 美东时间
2.91
+0.010
+0.34%
華盛通- 最 高3.40
- 今 開2.94
- 成交量 7.54万股
- 最 低 2.91
- 昨 收 2.90
- 總市值 228.92万
- 52周最高 2719.40
- 市盈率 靜 --
- 換手率 9.58%
- 52周最低 2.53
- 委 比 -31.43%
- 總股本 78.67万
- 歷史最高 75000000.00
- 量 比 2.77
- 振 幅 16.90%
- 歷史最低 2.91
- 每 手 1
- 風險率 701.62%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多CDT Equity Inc. Announces Reverse Stock Split
CDT Equity Inc. announces a 1-for-10 reverse stock split to maintain compliance with Nasdaq's bid-price rule. Effective July 17, 2026, every 10 shares will combine into 1 share, with trading resuming on July 20 under the same ticker "CDT." The company's common stock will have a new CUSIP number, and outstanding shares will reduce to approximately 631,077. Fractional shares will be settled with cash. The reverse split aims to ensure continued list...
07-16 12:00
Conduit Pharmaceuticals Q1 EPS $(5.56) Up From $(3.67 thousand) YoY
Conduit Pharmaceuticals (NASDAQ:CDT) reported quarterly losses of $(5.56) per share. This is a 99.85 percent increase over losses of $(3.67 thousand) per share from the same period last year.
07-16 06:15
CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development
CDT Equity Inc. announced that Sarborg Limited has expanded its Signature Intelligence platform into quantum-assisted coformer selection through SarborgQ, the Company's quantum computing division. Sarborg is integrating its proprietary datasets, AI architecture, and quantum computing to accelerate solid-form development, improve decision-making, and identify new co-crystal, salt, and solid-form opportunities. The initiative aims to enhance Sarbor...
06-26 12:30
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers PRF Technologies (NASDAQ:PRFX) stock rose 231.0% to $4.54 during Frida...
05-30 01:06
CDT Equity Receives Nasdaq Noncompliance Letter
CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced that the Company received a written notice ("Notice") from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on
05-29 04:24
CDT Equity Secures Canadian Patent Covering Use Of AZD5904 In Male Infertility
CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announces that the patent covering the use of AZD5904 in male infertility has now been granted in Canada, completing the approval of this patent in all key
05-27 20:03
CDT Announces Canadian Patent for AZD5904 in Male Infertility
CDT Equity Inc. announced the grant of a patent for AZD5904 in male infertility in Canada, completing approval in key markets. The extensive patent coverage and composition of matter application strengthen its IP position for development. AZD5904, originally licensed from AstraZeneca, addresses a significant unmet medical need in a $4.4 billion global market. The Canadian approval enhances global positioning as CDT advances partnering discussions...
05-27 12:00
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers BioLine Rx (NASDAQ:BLRX) stock increased by 12.5% to $3.11 during Mond...
05-19 05:05
CDT Equity Unit Sarborg Files Parent Covering Two Established Compounds Within The Cystic Fibrosis Market
Sarborg announced that the patent was developed using its proprietary Signature Agent and Multi-Agent platform, supported by its Sarborg 1,600 Disease Database and Sarborg 1,700 Rare Disease Database. According to
05-07 20:38
